Signoriello, E.
74  results:
Search for persons X
?
2

Lifestyle and Mediterranean diet adherence in a cohort of S..:

Esposito, S. ; Sparaco, M. ; Maniscalco, G.T....
Multiple Sclerosis and Related Disorders.  47 (2021)  - p. 102636 , 2021
 
?
3

Alemtuzumab significantly improves posterior fossa syndrome..:

Signoriello, E ; D'Amico, A ; Fratta, M...
Multiple Sclerosis and Related Disorders.  38 (2020)  - p. 101518 , 2020
 
?
4

Ocrelizumab in a case of refractory chronic inflammatory de..:

Casertano, S. ; Signoriello, E. ; Rossi, F....
European Journal of Neurology.  27 (2020)  12 - p. 2673-2675 , 2020
 
?
 
?
 
?
7

Is antibody titer useful to verify the immunization after V..:

Signoriello, E. ; Bonavita, S. ; Sinisi, L....
Multiple Sclerosis and Related Disorders.  40 (2020)  - p. 101963 , 2020
 
?
8

Clinical predictors of Dimethyl Fumarate response in multip..:

Lanzillo, R. ; Moccia, M. ; Palladino, R....
Multiple Sclerosis and Related Disorders.  38 (2020)  - p. 101871 , 2020
 
?
9

BMI influences CD20 kinetics in multiple sclerosis patients..:

Signoriello, E. ; Bonavita, S. ; Di Pietro, A....
Multiple Sclerosis and Related Disorders.  43 (2020)  - p. 102186 , 2020
 
?
12

Adiponectin profile at baseline is correlated to progressio..:

Signoriello, E. ; Lus, G. ; Polito, R....
European Journal of Neurology.  26 (2018)  2 - p. 348-355 , 2018
 
?
13

Clinical activity after fingolimod cessation: disease react..:

Frau, J. ; Sormani, M. P. ; Signori, A....
European Journal of Neurology.  25 (2018)  10 - p. 1270-1275 , 2018
 
?
14

Migraine as possible red flag of PFO presence in suspected ..:

Signoriello, E. ; Cirillo, M. ; Puoti, G....
Journal of the Neurological Sciences.  390 (2018)  - p. 222-226 , 2018
 
?
15

Fingolimod efficacy in multiple sclerosis associated with S..:

Signoriello, E. ; Sagliocchi, A. ; Fratta, M..
Acta Neurologica Scandinavica.  131 (2015)  2 - p. 140-143 , 2015
 
1-15